Aviance Capital Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $287K | Sell |
3,998
-497
| -11% | -$38.3K | 0.03% | 316 |
|
|
2025
Q4 | $357K | Sell |
4,495
-7
| -0.2% | -$552 | 0.04% | 279 |
|
|
2025
Q3 | $339K | Buy |
4,502
+2
| +0% | +$137 | 0.04% | 285 |
|
|
2025
Q2 | $310K | Buy |
4,500
+1
| +0% | +$66 | 0.04% | 284 |
|
|
2025
Q1 | $305K | Buy |
+4,499
| New | +$269K | 0.04% | 279 |
|
|
2024
Q4 | – | Sell |
-9,460
| Closed | -$595K | – | 332 |
|
|
2024
Q3 | $595K | Sell |
9,460
-496
| -5% | -$28.9K | 0.08% | 208 |
|
|
2024
Q2 | $588K | Sell |
9,956
-1,713
| -15% | -$107K | 0.08% | 195 |
|
|
2024
Q1 | $931K | Buy |
11,669
+710
| +6% | +$54.2K | 0.14% | 157 |
|
|
2023
Q4 | $865K | Buy |
10,959
+19
| +0.2% | +$1.35K | 0.19% | 129 |
|
|
2023
Q3 | $764K | Buy |
10,940
+963
| +10% | +$68.2K | 0.17% | 140 |
|
|
2023
Q2 | $690K | Buy |
9,977
+2
| +0% | +$142 | 0.15% | 157 |
|
|
2023
Q1 | $741K | Sell |
9,975
-149
| -1% | -$12.5K | 0.16% | 146 |
|
|
2022
Q4 | $943K | Buy |
10,124
+52
| +0.5% | +$5.02K | 0.22% | 129 |
|
|
2022
Q3 | $961K | Buy |
10,072
+40
| +0.4% | +$3.96K | 0.24% | 122 |
|
|
2022
Q2 | $930K | Sell |
10,032
-149
| -1% | -$14.5K | 0.21% | 135 |
|
|
2022
Q1 | $1.03M | Buy |
10,181
+6
| +0.1% | +$630 | 0.19% | 138 |
|
|
2021
Q4 | $1.05M | Hold |
10,175
| – | – | 0.17% | 138 |
|
|
2021
Q3 | $863K | Hold |
10,175
| – | – | 0.15% | 148 |
|
|
2021
Q2 | $849K | Buy |
10,175
+221
| +2% | +$18.1K | 0.15% | 161 |
|
|
2021
Q1 | $749K | Sell |
9,954
-325
| -3% | -$23.7K | 0.14% | 170 |
|
|
2020
Q4 | $702K | Buy |
10,279
+700
| +7% | +$45.5K | 0.14% | 155 |
|
|
2020
Q3 | $559K | Hold |
9,579
| – | – | 0.13% | 158 |
|
|
2020
Q2 | $622K | Sell |
9,579
-940
| -9% | -$59.2K | 0.15% | 146 |
|
|
2020
Q1 | $624K | Sell |
10,519
-427
| -4% | -$28.5K | 0.2% | 126 |
|
|
2019
Q4 | $813K | Sell |
10,946
-624
| -5% | -$43.8K | 0.21% | 125 |
|
|
2019
Q3 | $730K | Sell |
11,570
-1,210
| -9% | -$71.7K | 0.21% | 128 |
|
|
2019
Q2 | $696K | Sell |
12,780
-1,916
| -13% | -$103K | 0.19% | 141 |
|
|
2019
Q1 | $793K | Sell |
14,696
-3,990
| -21% | -$246K | 0.23% | 128 |
|
|
2018
Q4 | $1.22M | Buy |
18,686
+5,726
| +44% | +$427K | 0.43% | 62 |
|
|
2018
Q3 | $1.02M | Hold |
12,960
| – | – | 0.25% | 106 |
|
|
2018
Q2 | $833K | Sell |
12,960
-219
| -2% | -$14.4K | 0.24% | 120 |
|
|
2018
Q1 | $819K | Sell |
13,179
-988
| -7% | -$70.9K | 0.25% | 124 |
|
|
2017
Q4 | $1.03M | Sell |
14,167
-11,832
| -46% | -$860K | 0.34% | 83 |
|
|
2017
Q3 | $2.11M | Sell |
25,999
-1,155
| -4% | -$91.4K | 0.71% | 29 |
|
|
2017
Q2 | $2.19M | Buy |
27,154
+780
| +3% | +$61.6K | 0.7% | 34 |
|
|
2017
Q1 | $2.07M | Sell |
26,374
-545
| -2% | -$43.5K | 0.76% | 31 |
|
|
2016
Q4 | $2.12M | Sell |
26,919
-2,721
| -9% | -$220K | 0.75% | 31 |
|
|
2016
Q3 | $2.64M | Buy |
29,640
+1,645
| +6% | +$155K | 0.93% | 25 |
|
|
2016
Q2 | $2.68M | Sell |
27,995
-250
| -0.9% | -$24.9K | 0.99% | 22 |
|
|
2016
Q1 | $2.93M | Sell |
28,245
-960
| -3% | -$93.3K | 1.02% | 16 |
|
|
2015
Q4 | $2.85M | Sell |
29,205
-3,034
| -9% | -$297K | 0.98% | 19 |
|
|
2015
Q3 | $3.11M | Buy |
32,239
+175
| +0.5% | +$18.4K | 1.28% | 10 |
|
|
2015
Q2 | $3.36M | Buy |
32,064
+280
| +0.9% | +$28.6K | 1.26% | 11 |
|
|
2015
Q1 | $3.28M | Sell |
31,784
-190
| -0.6% | -$19.2K | 1.2% | 10 |
|
|
2014
Q4 | $3.08M | Buy |
31,974
+669
| +2% | +$58.9K | 1.15% | 12 |
|
|
2014
Q3 | $2.49M | Sell |
31,305
-385
| -1% | -$30.4K | 0.94% | 17 |
|
|
2014
Q2 | $2.39M | Buy |
31,690
+2,050
| +7% | +$155K | 0.93% | 19 |
|
|
2014
Q1 | $2.22M | Sell |
29,640
-6,295
| -18% | -$445K | 0.94% | 22 |
|
|
2013
Q4 | $2.57M | Buy |
35,935
+1,450
| +4% | +$93.2K | 1.08% | 18 |
|
|
2013
Q3 | $1.96M | Buy |
34,485
+250
| +0.7% | +$14.9K | 0.92% | 26 |
|
|
2013
Q2 | $1.96M | Buy |
+34,235
| New | +$1.98M | 1.06% | 23 |
|
Other funds holding CVS
VCM
VPM
Aviance Capital Partners's CVS Position: Q1 2026 in Review
Aviance Capital Partners reduced its CVS Health (CVS) stake by 11% in Q1 2026, selling an estimated $38.3K and leaving 3,998 shares worth $287K. The position accounts for 0.03% of the portfolio, ranked #316.
Aviance Capital Partners first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.36M in Q2 2015. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Aviance Capital Partners held 3,998 shares of CVS Health worth $287K as of Q1 2026.
- Aviance Capital Partners sold 497 CVS Health shares in Q1 2026, an estimated $38.3K.
- CVS Health made up 0.03% of Aviance Capital Partners's portfolio in Q1 2026, its #316 holding.
- Aviance Capital Partners first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
- Aviance Capital Partners's CVS Health position peaked at $3.36M in Q2 2015.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.